Diagnostic Pathology: Molecular Oncology: 2ed
Covering all aspects of molecular pathology as it relates to the transformation and pathogenesis of cancer, this award-winning volume in the Diagnostic Pathology series is an expert resource for pathologists at all levels of experience and training, both as a quick reference and as an efficient review to improve knowledge and skills.
Diagnostic Pathology: Molecular Oncology: 2ed
Covering all aspects of molecular pathology as it relates to the transformation and pathogenesis of cancer, this award-winning volume in the Diagnostic Pathology series is an expert resource for pathologists at all levels of experience and training, both as a quick reference and as an efficient review to improve knowledge and skills. This easily accessible, point-of-care reference features templated, bulleted content that is generously illustrated with charts, graphs, tables, and color photomicrographs of histology with special stains. It offers a practical, clinical approach to examining how molecular mutations affect common medical diseases and identifies the relevant and appropriate molecular tests to perform for a complete work-up in the era of molecular-targeted therapies.
- Provides updated information on molecular mutations in different tumors, including solid tumors and hematopoietic neoplasms, and new targeted therapies geared toward these molecular alterations
- Discusses now widely used immunotherapy treatments, including how immunotherapy has revolutionized the treatment of many neoplasms such as breast and lung carcinomas and lymphoma
- Features more than 2,000 annotated images throughout, including H&E stains, immunostains, and FISH images
Covers timely topics such as:
- Recent advances in cancer immunotherapy, specifically in the molecular basis of immunotherapy
- Newly discovered targeted therapies, including multiple lung carcinoma therapies now considered for patients based on existing mutations to specific genes (KRAS, ALK, BRAF, and ROS)
- The need for integration of myeloid and lymphoid gene panels due to increased knowledge from next generation sequencing studies of new mutations and the resulting newly developed molecular targets
- Increased usage of next generation sequencing techniques
- Changes to hematopoietic tumor details based on revised WHO guidelines
- Recipient of a 2016 BMA Award: Highly Commended, Pathology (previous edition)
| Book | |
|---|---|
| Author | Vasef, Mohammed A. |
| Pages | 1016 |
| Year | 7/31/2019 |
| ISBN | 9780323611442 |
| Publisher | Elsevier |
| Language | English |
| Uncategorized | |
| Edition | 2/e |
| Weight | 3.08 |
| Binding | Hardcover |